Catasys, Inc. · Los Angeles, CA United States (OTC: CATS)
| 11150 Santa Monica Blvd., Ste. 1500 | Phone: 310-444-4300 |
| Los Angeles, CA | Fax: 310-444-5300 |
| 90025 | |
| United States |
Catasys, Inc. Rankings
Company Description
Catasys (formerly known as Hythiam) specializes in researching, developing, and licensing medical protocols for the treatment of alcohol and drug addiction. The company's PROMETA treatment programs utilize a combination of medication, nutritional supplements, and counseling to treat drug and alcohol addiction. Catasys' PROMETA Centers are operated through management or licensing agreements with health care providers in the US. PROMETA also provides maintenance support by offering individualized care programs following medically supervised treatment. Namesake program Catasys offers disease management services. The company changed its name in 2011 to reflect its focus on comprehensive behavioral management.
Financials
| Company Type | Public - OTC: CATS Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 33 |
Executives
11 executives listed for Catasys, Inc.'s Los Angeles, CA location.
| Chairman and CEO | Terren Peizer | |
|---|---|---|
| President, COO, and Director | Richard Anderson | |
| CFO | Peter Donato |


